Baclofen
In clinical developmentAlso known as 4-Amino-3-(4-chlorophenyl)butyric acid, Fleqsuvy, Gablofen, Lioresal+10 more
4-Amino-3-(4-chlorophenyl)butyric acid, Fleqsuvy, Gablofen, Lioresal, Lyvispah, Ozobax, beta-(4-Chlorophenyl)gaba, beta-(Aminomethyl)-4-chlorobenzenepropanoic acid, beta-(Aminomethyl)-p-chlorohydrocinnamic acid, beta-(p-Chlorophenyl)-gamma-aminobutyric acid, gamma-Amino-beta-(p-chlorophenyl)butyric acid, Baclofeno, Baclofène, Baclofenum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Synaptic Mechanisms of Continuous Theta Burst Stimulation in Depression
Baclofen for Improving Benzodiazepine Titration in Benzodiazepine Dependence
Baclofen Versus Gabapentin in Preventing Postoperative Pain After Laparoscopic Sleeve
Efficacy of Baclofen Vs Naltrexon in Achieving & Maintaining Abstinence in Alcohol Dependence.
A Randomized Controlled Pilot Trial of Baclofen for Children With Rumination Syndrome
A human laboratory pilot study with baclofen in alcoholic individuals.
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Pharmacology & targets
Known molecular targets and mechanisms supported by curated pharmacology databases.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Baclofen as a Perioperative Analgesic Adjuvant
Baclofen Bij de Behandeling Van Acute Alcoholontwenning
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Major research themes3
Journals, researchers & institutions
- Journal of clinical oncology : official journal of the American Society of Clinical Oncology1
- Pharmacology, biochemistry, and behavior1
- Translational psychiatry1
- Trials1
- Leggio L2
- Addolorato G1
- Amodio JP1
- Bak K1
- Barker D1
- Bleeker J1
- Bollinger JW1
- Cavaletti G1
- Center for Alcohol and Addiction Studies2
- Clinical Center Nursing Department1
- Columbia University Medical Center1
- Imperial Clinical Trials Unit1
- Imperial College London1
- Office of the Clinical Director1
Related drugs
Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).
Studied across 3 of the same disease areas as Baclofen in the shared literature.
Studied across 3 of the same disease areas as Baclofen in the shared literature.
Studied across 3 of the same disease areas as Baclofen in the shared literature.
Studied across 3 of the same disease areas as Baclofen in the shared literature.
Studied across 3 of the same disease areas as Baclofen in the shared literature.
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials